Global Meningococcal Vaccine Market by Player, Region, Type, Application and Sales Channel

  • Report Code : MAR2645406
  • Published On: Apr, 2023
  • Category : Medical Devices
  • Pages : 99
  • This report studies the Meningococcal Vaccine market, covering market size for segment by type (Quadrivalent, Bivalent, etc.), by application (Pneumonia, Meningitis, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Novartis, GSK, Merck, CSL, Baxter, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).


    This report provides detailed historical analysis of global market for Meningococcal Vaccine from 2017-2022, and provides extensive market forecasts from 2023-2031 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Meningococcal Vaccine market.


    Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.


    This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.


    The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.


    Leading players of Meningococcal Vaccine including:

    Novartis

    GSK

    Merck

    CSL

    Baxter

    JN International Medical Corporation

    Serum Institute of India

    Bio-Med

    China National Biotec Group

    Hualan Bio

    Walvax

    Zhifei


    Market split by Type, can be divided into:

    Quadrivalent

    Bivalent

    Others


    Market split by Application, can be divided into:

    Pneumonia

    Meningitis

    Bacteremia

    Others


    Market split by Sales Channel, can be divided into:

    Direct Channel

    Distribution Channel


    Market segment by Region/Country including:

    North America (United States, Canada and Mexico)

    Europe (Germany, UK, France, Italy, Russia and Spain etc.)

    Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)

    South America (Brazil, Argentina and Colombia etc.)

    Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)


    If you have any special requirements, please let us know and we can provide you the customized report as you want.


     

  • With tables and figures helping analyze worldwide Global Meningococcal Vaccine market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

    Chapter 1 Meningococcal Vaccine Market Overview

    1.1 Meningococcal Vaccine Definition

    1.2 Global Meningococcal Vaccine Market Size Status and Outlook (2017-2031)

    1.3 Global Meningococcal Vaccine Market Size Comparison by Region (2017-2031)

    1.4 Global Meningococcal Vaccine Market Size Comparison by Type (2017-2031)

    1.5 Global Meningococcal Vaccine Market Size Comparison by Application (2017-2031)

    1.6 Global Meningococcal Vaccine Market Size Comparison by Sales Channel (2017-2031)

    1.7 Meningococcal Vaccine Market Dynamics
    1.7.1 Market Drivers/Opportunities
    1.7.2 Market Challenges/Risks
    1.7.3 Market News (Mergers/Acquisitions/Expansion)
    1.7.4 COVID-19 Impacts
    1.7.5 Russia-Ukraine War Impacts
    Chapter 2 Meningococcal Vaccine Market Segment Analysis by Player

    2.1 Global Meningococcal Vaccine Sales and Market Share by Player (2020-2022)

    2.2 Global Meningococcal Vaccine Revenue and Market Share by Player (2020-2022)

    2.3 Global Meningococcal Vaccine Average Price by Player (2020-2022)

    2.4 Players Competition Situation & Trends

    2.5 Conclusion of Segment by Player

    Chapter 3 Meningococcal Vaccine Market Segment Analysis by Type

    3.1 Global Meningococcal Vaccine Market by Type

    3.1.1 Quadrivalent
    3.1.2 Bivalent
    3.1.3 Others

    3.2 Global Meningococcal Vaccine Sales and Market Share by Type (2017-2022)

    3.3 Global Meningococcal Vaccine Revenue and Market Share by Type (2017-2022)

    3.4 Global Meningococcal Vaccine Average Price by Type (2017-2022)

    3.5 Leading Players of Meningococcal Vaccine by Type in 2022

    3.6 Conclusion of Segment by Type

    Chapter 4 Meningococcal Vaccine Market Segment Analysis by Application

    4.1 Global Meningococcal Vaccine Market by Application

    4.1.1 Pneumonia
    4.1.2 Meningitis
    4.1.3 Bacteremia
    4.1.4 Others

    4.2 Global Meningococcal Vaccine Revenue and Market Share by Application (2017-2022)

    4.3 Leading Consumers of Meningococcal Vaccine by Application in 2022

    4.4 Conclusion of Segment by Application

    Chapter 5 Meningococcal Vaccine Market Segment Analysis by Sales Channel

    5.1 Global Meningococcal Vaccine Market by Sales Channel

    5.1.1 Direct Channel
    5.1.2 Distribution Channel

    5.2 Global Meningococcal Vaccine Revenue and Market Share by Sales Channel (2017-2022)

    5.3 Leading Distributors/Dealers of Meningococcal Vaccine by Sales Channel in 2022

    5.4 Conclusion of Segment by Sales Channel

    Chapter 6 Meningococcal Vaccine Market Segment Analysis by Region

    6.1 Global Meningococcal Vaccine Market Size and CAGR by Region (2017-2031)

    6.2 Global Meningococcal Vaccine Sales and Market Share by Region (2017-2022)

    6.3 Global Meningococcal Vaccine Revenue and Market Share by Region (2017-2022)

    6.4 North America

    6.4.1 North America Market by Country
    6.4.2 North America Meningococcal Vaccine Market Share by Type
    6.4.3 North America Meningococcal Vaccine Market Share by Application
    6.4.4 United States
    6.4.5 Canada
    6.4.6 Mexico

    6.5 Europe

    6.5.1 Europe Market by Country
    6.5.2 Europe Meningococcal Vaccine Market Share by Type
    6.5.3 Europe Meningococcal Vaccine Market Share by Application
    6.5.4 Germany
    6.5.5 UK
    6.5.6 France
    6.5.7 Italy
    6.5.8 Russia
    6.5.9 Spain

    6.6 Asia-Pacific

    6.6.1 Asia-Pacific Market by Country
    6.6.2 Asia-Pacific Meningococcal Vaccine Market Share by Type
    6.6.3 Asia-Pacific Meningococcal Vaccine Market Share by Application
    6.6.4 China
    6.6.5 Japan
    6.6.6 Korea
    6.6.7 India
    6.6.8 Southeast Asia
    6.6.9 Australia
    6.7 South America
    6.7.1 South America Market by Country
    6.7.2 South America Meningococcal Vaccine Market Share by Type
    6.7.3 South America Meningococcal Vaccine Market Share by Application
    6.7.4 Brazil
    6.7.5 Argentina
    6.7.6 Colombia
    6.8 Middle East & Africa
    6.8.1 Middle East & Africa Market by Country
    6.8.2 Middle East & Africa Meningococcal Vaccine Market Share by Type
    6.8.3 Middle East & Africa Meningococcal Vaccine Market Share by Application
    6.8.4 UAE
    6.8.5 Saudi Arabia
    6.8.6 South Africa
    6.9 Conclusion of Segment by Region
    Chapter 7 Profile of Leading Meningococcal Vaccine Players

    7.1 Novartis

    7.1.1 Company Snapshot
    7.1.2 Product/Service Offered
    7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

    7.2 GSK

    7.3 Merck

    7.4 CSL

    7.5 Baxter

    7.6 JN International Medical Corporation

    7.7 Serum Institute of India
    7.8 Bio-Med
    7.9 China National Biotec Group

    7.10 Hualan Bio

    7.11 Walvax
    7.12 Zhifei
    Chapter 8 Upstream and Downstream Analysis of Meningococcal Vaccine

    8.1 Industrial Chain of Meningococcal Vaccine

    8.2 Upstream of Meningococcal Vaccine

    8.3 Downstream of Meningococcal Vaccine

    Chapter 9 Development Trend of Meningococcal Vaccine (2023-2031)

    9.1 Global Meningococcal Vaccine Market Size (Sales and Revenue) Forecast (2023-2031)

    9.2 Global Meningococcal Vaccine Market Size and CAGR Forecast by Region (2023-2031)

    9.3 Global Meningococcal Vaccine Market Size and CAGR Forecast by Type (2023-2031)

    9.4 Global Meningococcal Vaccine Market Size and CAGR Forecast by Application (2023-2031)

    9.5 Global Meningococcal Vaccine Market Size and CAGR Forecast by Sales Channel (2023-2031)

    Chapter 10 Appendix

    10.1 Research Methodology

    10.2 Data Sources

    10.3 Disclaimer

    10.4 Analysts Certification

     

  • The Global Meningococcal Vaccine Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

    Report Objectives / Segmentation Covered :
    By Companies / players:
      By Regions:
        By Type:
          By Application:
          Frequently asked questions(FAQ's):
          Why are some of the most well-known companies left out of the Global Meningococcal Vaccine Market study?

          The Global Meningococcal Vaccine study includes a diverse group of participants, including both market leaders and up-and-comers. Contact our sales representative to receive a complete list of companies covered in the study.

          What is the anticipated growth rate for the Global Meningococcal Vaccine Market?

          During the projected year from 2024 to 2029, the Global Meningococcal Vaccine Market is expected to grow at a CAGR of xx%.

          In the current situation, what value does the Global Meningococcal Vaccine Market have?

          The value of the Global Meningococcal Vaccine Market is estimated to be USD XXX million.

          How is the competitive landscape for the Global Meningococcal Vaccine Market defined?

          Companies in the Global Meningococcal Vaccine Industry are thoroughly researched and profiled in order to determine why certain trends will have a significant impact and how they will be factored into the Global Meningococcal Vaccine Market's trajectory and future outlook.

          Our Clients